How to use these pharmaceutics practice questions

These single-best-answer questions cover core pharmaceutics principles, including calculations, dosage forms, dissolution and stability. No particular examination or jurisdiction is specified, so they are practice questions on the subject rather than a claim about any exam’s format. If you are preparing for a named qualification, check its official syllabus and assessment guidance, then use your own notes to identify any additional topics.

Choose an option for each question before reading the explanation beneath it. For each answer, be able to say both why it is correct and why the closest alternative is not. That distinction matters in formulation questions, where two options may sound reasonable but only one follows from the given data.

1. Converting a prescribed dose to a liquid volume

This tests dose-volume calculation and unit handling.

A MySummaries question screen for a liquid-dose calculation looks like this:

Question 11 mark

A patient is prescribed 375 mg of an oral medicine. The available liquid contains 250 mg in 5 mL. What volume should be measured for one dose?

The concentration is 250 mg ÷ 5 mL = 50 mg/mL. The required volume is 375 mg ÷ 50 mg/mL = 7.5 mL. The strongest distractor, 5 mL, supplies only 250 mg.

Check the units as well as the arithmetic: dividing the dose in milligrams by the concentration in milligrams per millilitre leaves millilitres.

2. Geometric dilution

This tests how to distribute a small amount of potent powder through a larger quantity of diluent.

Question 21 mark

A 100 mg quantity of a potent powder must be mixed uniformly with 900 mg of lactose. Which method is most appropriate?

Geometric dilution progressively increases the bulk around the small quantity of potent powder, supporting more uniform distribution. Adding all the diluent at once risks leaving the active ingredient unevenly dispersed; brief stirring does not correct that reliably.

The method is especially useful when the active ingredient is present in a much smaller mass than the diluent. The exact mixing process should still follow the applicable formulation procedure.

3. First-order degradation

This tests half-life reasoning for a medicine that follows first-order degradation under the stated conditions.

Question 31 mark

A solution degrades by first-order kinetics and has a half-life of 6 hours at a stated temperature. What fraction of the original drug remains after 12 hours at that temperature?

Twelve hours is two half-lives. After the first 6 hours, 50% remains; after the next 6 hours, half of that remains, or 25% of the original amount. The strongest distractor, 50%, is the amount remaining after only one half-life.

The condition “at that temperature” matters: degradation rates can change with storage conditions, so a half-life cannot automatically be carried over to a different temperature.

4. Weak-acid solubility and pH

This tests the relationship between pH, pKa and the ionised fraction of a weak acid.

Question 41 mark

For a weak acid with pKa 4.0, what is the ratio of ionised to unionised drug at pH 6.0, assuming ideal behaviour?

For a weak acid, the Henderson–Hasselbalch relationship gives ionised:unionised = 10^(pH − pKa). Here the difference is 2, so the ratio is 10²:1, or 100:1. The 10:1 distractor would correspond to a pH one unit above the pKa.

This ratio concerns ionisation, not a guarantee that the total solubility will increase by exactly the same factor in a real formulation. The equation is a useful starting point; formulation conditions can complicate the result.

5. Increasing dissolution rate

This tests the effect of particle surface area on dissolution, with the other conditions held constant.

Question 51 mark

Under the Noyes–Whitney model, which change is expected to increase the dissolution rate of a poorly soluble solid when other relevant conditions are held constant?

Reducing particle size increases the total exposed surface area for a given mass, which can increase dissolution rate. The strongest distractor is increasing diffusion-layer thickness: a thicker layer increases the diffusion path and tends to reduce the rate.

Micronisation can improve dissolution by increasing surface area, but it does not by itself guarantee improved bioavailability. The effects on wetting, aggregation and the final dosage form also matter.

6. Sterilising a heat-sensitive solution

This tests selection of a sterilisation approach for a solution that cannot tolerate heat.

Question 61 mark

An aqueous formulation is heat-sensitive and must be prepared as a sterile product. Which approach is most appropriate when the solution is filterable and the ingredients are compatible with the process?

For a heat-sensitive, filterable solution, validated sterilising-grade filtration followed by aseptic processing is an appropriate approach. The strongest distractor, coarse filtration, may remove larger particles but is not a sterilising process. A preservative is not a substitute for sterilisation.

The words “validated” and “aseptic filling” are important: filtration alone does not protect the product from contamination during later handling. Requirements depend on the product and applicable standards.

7. Modified-release tablets

This tests safe handling of a dosage form designed to release medicine over time.

Question 71 mark

A patient cannot swallow a modified-release tablet. What is the safest initial advice?

Modified-release products must not be altered unless product-specific instructions confirm that a particular method is safe. Crushing can disrupt the release mechanism and cause rapid release. The strongest distractor, splitting, is not automatically safe either; it depends on the specific product.

Do not generalise from one brand or formulation to another. Check the product information or ask a pharmacist before splitting, crushing or dispersing a modified-release product.

8. Moisture protection

This tests packaging selection for a moisture-sensitive solid dosage form.

Question 81 mark

A solid dose is hygroscopic and loses stability when exposed to moisture. Which packaging choice best addresses the identified risk, assuming compatibility and the required protection level are confirmed?

A suitable moisture-barrier pack and effective seal limit moisture ingress. A paper sachet or loosely closed container offers less protection, while extra headspace does not solve the moisture barrier problem. The precise packaging must be supported by product stability data.

Packaging is part of the formulation strategy, not an afterthought. The selected material and closure should be supported by stability and compatibility evidence.

9. Emulsion stability

This tests identification of a physical instability in an emulsion.

Question 91 mark

An emulsion develops a distinct layer of droplets at the top during storage, but gentle shaking restores its original appearance. Which instability is most consistent with this observation?

Creaming is the upward or downward concentration of dispersed droplets under gravity and may be reversible on shaking. The strongest distractor, cracking, is irreversible separation of the emulsion into phases; gentle shaking does not restore the original emulsion.

The distinction between reversible creaming and irreversible cracking helps direct investigation. A restored appearance does not, on its own, establish that a product remains within its specifications.

10. Dilution of a stock solution

This tests use of the dilution equation while keeping the final volume clear.

Question 101 mark

How much of a 2% w/v stock solution is needed to prepare 100 mL of a 0.5% w/v solution?

Using C1V1 = C2V2, V1 = (0.5% × 100 mL) ÷ 2% = 25 mL. Measure 25 mL of stock and add diluent to a final volume of 100 mL. The strongest distractor, 50 mL, would produce a 1% w/v solution when made up to 100 mL.

“Make up to 100 mL” means the final solution volume is 100 mL; it does not mean adding 100 mL of diluent to the stock.

Short-answer practice: show the working

A multiple-choice score can conceal whether your calculation method is reliable. Practise stating the equation, substituting the values, giving the result and naming the final-volume step. This marked example uses platform feedback on a practice answer; it does not represent an official examination mark scheme.

Paper — Pharmaceutics — solutions and calculations04:10
75%Pharmaceutics — solutions and calculations — marked3/4 marks · 04:10 taken

Use a 2% w/v stock solution to prepare 100 mL of a 0.5% w/v solution. State the volume of stock required and how to complete the preparation.

3/4

Using C1V1 = C2V2: V1 = (0.5 × 100)/2 = 25 mL. Measure 25 mL of stock and add diluent to 100 mL.

The calculation and final-volume instruction are correct. Make the concentration basis explicit: both values are % w/v, so the dilution equation is being applied on the same basis.

Missed

State that the final volume is brought up to 100 mL, rather than adding 100 mL of diluent.

Model answerBoth concentrations are expressed as % w/v, so use C1V1 = C2V2. V1 = (0.5% × 100 mL) ÷ 2% = 25 mL. Measure 25 mL of the 2% w/v stock. Add a suitable diluent and bring the final volume to 100 mL. Mix thoroughly.

That is a MySummaries paper, filled with pharmaceutics material. Yours is written from your own notes. Start free

Use your errors to choose what to revise

After answering, record the principle behind each error: unit conversion, equation selection, assumptions or product-specific safety. A wrong answer caused by a unit error needs different practice from one caused by confusing creaming with cracking. Check the relevant section of your own notes, then try a fresh question without relying on the remembered options.

The following practice summary ranks topics by recent performance; its frequencies refer to this question set, not to any examination’s topic weighting.

Where marks go missing
50%Calculations and dilution2×
67%Physical stability2×
100%Dissolution and dosage forms3×

When a calculation error recurs, turn the missed step into a small retrieval prompt. For example: “When using C1V1 = C2V2, what does the final volume refer to?” Answer it aloud, then check the explanation and your notes.

Remediation tray

You lost this mark twice: in C1V1 = C2V2, does V2 mean the volume of diluent added or the final total volume?

Add cardDismiss

How MySummaries helps

Build a revision board from your own pharmaceutics notes, then use it to generate question practice, flashcards and written mock exams marked against that material. Review repeated errors alongside the relevant source section, so your next practice session targets a specific gap. Open MySummaries.